---
title: CARB-X
date: 2018-03-13
start_date: Proposed in 2016
description: A biopharmaceutical incubator with the aim of accelerating a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development by leveraging $450 million in BARDA funds with matching funds from Wellcome Trust.
status: Operational
---
